A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

NCT01725256 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
29
Enrollment
INDUSTRY
Sponsor class

Stopped Terminated early dt to acquisition of Sponsor and change in corporate priorities

Conditions

Interventions

Sponsor

Aires Pharmaceuticals, Inc.